Cytek Biosciences (NASDAQ:CTKB) Trading Down 7.6%

Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) were down 7.6% during trading on Thursday . The stock traded as low as $8.06 and last traded at $8.08. Approximately 256,052 shares traded hands during trading, a decline of 61% from the average daily volume of 649,054 shares. The stock had previously closed at […]

Related Keywords

Kentucky ,United States ,Cytek Biosciences ,Ming Yan ,Patrik Jeanmonod ,Barclays Plc ,Nasdaq ,Vanguard Group Inc ,Cytek Biosciences Inc ,Goldman Sachs Group ,Cytek Biosciences Company Profile ,Group Plc ,Pricet Rowe Associates Inc ,Securities Exchange Commission ,Morgan Stanley ,Get Free Report ,Biosciences Stock Down ,Exchange Commission ,Retirement System ,General Group Plc ,Vanguard Group ,Cytek Biosciences Daily ,Nasdaq Ctkb ,Ctkb ,Medical ,Stocks ,Technicals ,